Digital Pharma: Social media an ‘enigma’ for pharma
July 15, 2010Medical Communications Cegedim, Digital Pharma blog, digital pharma, industry, social media
The vast majority of pharma companies now use social media in one form or another, but it is unclear how …
GSK accused of Avandia cover-up
July 14, 2010Sales and Marketing Avandia, GlaxoSmithKline, diabetes
The ongoing battle over GlaxoSmithKline’s diabetes drug Avandia has taken another turn with US senators accusing the company of a …
Power to the project manager
July 14, 2010Research and Development Les Rose, project management
It’s an interesting exercise to peruse the job ads these days, even if you are not actually looking for a …
Amgen’s Marc de Garidel elected EBE president
July 14, 2010Research and Development Amgen, European Biopharmaceutical Enterprises, appointment, research and development
Brussels-based industry association the European Biopharmaceutical Enterprises has elected Amgen’s Marc de Garidel as its new president. He will serve …
ClinTec appoints Susan Pavone
July 14, 2010Research and Development ClinTec, appointment, research and development
ClinTec International has appointed Susan Pavone as associate director of US business operations as part of moves to expand its …
AstraZeneca extends siRNA collaboration
July 14, 2010Research and Development AstraZeneca, RNA, Silence Therapeutics
AstraZeneca has agreed a one-year extension on its siRNA development collaboration with London-based Silence Therapeutics. Silence is a specialist in …
Astellas taps into overactive bladder market with garden display
July 13, 2010Medical Communications Astellas, Vesicare, disease awareness campaigns, overactive bladder
Astellas has launched a campaign to raise awareness of overactive bladder with the help of an award winning garden designer …
Stem cell trial for osteoarthritis launched
July 13, 2010Research and Development Arthritis Research UK, Stem cells, osteoarthritis
Stem cell therapy is to be used to treat patients with osteoarthritis in a new UK clinical trial. Medical research …
Genzyme says it will double size of its Framingham site
July 13, 2010Manufacturing and Production Genzyme
Genzyme has unveiled a major expansion of its manufacturing facility in Framingham, Massachusetts, which suggests that the company intends to …
Talking Point: The role of air-freight
July 13, 2010Manufacturing and Production Swiss World Cargo, logistics, supply chain, talking logistics
The air-freight carrier can play a key role in the shipment of pharmaceuticals, and must be viewed as part of …
Contract research news in brief
July 13, 2010Research and Development Charles River Laboratories, ClinTec, ICON, Quintiles, Synexus, Technical Resources International, WuXi
Charles River places its proposal to merge with China’s WuXi PharmaTech in front of its shareholders, while ClinTec and Synexus …
Radical NHS reform unveiled
July 13, 2010GP, NHS, government
Radical reforms of the NHS have been unveiled which will give GPs control of the health system spending and see current management structures …
Value-based pricing for UK pharma by 2014
July 13, 2010Sales and Marketing government, pricing
The UK government plans to radically overhaul the way medicines are paid for, introducing a value-based pricing system within the …
College Hill Life Sciences expands
July 13, 2010Medical Communications College Hill, appointment, medical communications
International business communications consultancy College Hill has strengthened its Life Sciences team with the appointment of senior account director Nicole …
Digital Pharma: Byte-sized roundup
July 12, 2010Medical Communications, Sales and Marketing Code of Practice, Digital Pharma blog, digi game, disease awareness campaigns
This week’s roundup includes a sexual health computer game, a powerful new search tool, US health apps and a reprimand …
Huntsworth acquires ScopeMedical
July 12, 2010Medical Communications Huntsworth, ScopeMedical
UK communications group Huntsworth has acquired ScopeMedical in a deal that could be worth up to £11 million. The Kent-based …
Avandia to face European safety review
July 12, 2010Sales and Marketing Avandia, GlaxoSmithKline, diabetes
GlaxoSmithKline’s type II diabetes drug Avandia, the subject of safety concerns since its launch in 2000, is to be reviewed …
NICE rejects Takeda cancer drug over price concerns
July 12, 2010Sales and Marketing Cancer, Mepact, NICE, Takeda, bone cancer
UK cost-effectiveness watchdog NICE has rejected Takeda’s orphan bone cancer drug Mepact due to concerns over price. In its draft …
First oral MS treatment approved in Russia
July 12, 2010Sales and Marketing Cladribine, MS, Merck Serono, Movectro
Regulators in Russia have approved Merck Serono’s cladribine, lining up the drug to be the first oral treatment for multiple …
Annemarie den Broeder joins WorldEvents
July 12, 2010Sales and Marketing WorldEvents, appointment, sales and marketing
UK event agency WorldEvents has appointed Annemarie den Broeder as a senior account manager to its Amsterdam office. Annemarie is …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
